{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:40:42Z","timestamp":1786621242090,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25H02003"],"award-info":[{"award-number":["JP25H02003"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24H01059"],"award-info":[{"award-number":["JP24H01059"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nucmedbio.2026.109638","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:10:52Z","timestamp":1779721852000},"page":"109638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Importance of an alkyl group inserted into the DOTA backbone for reducing renal radioactivity levels of 111In-labeled antibody fragments"],"prefix":"10.1016","volume":"158-159","author":[{"given":"Hiroyuki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Kannaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiro","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Arano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2026.109638_bb0005","first-page":"693","article-title":"Targeted therapy of cancer with radiolabeled antibodies","volume":"43","author":"Goldenberg","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0010","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/cancers14061454","article-title":"Radiolabeled antibodies for cancer imaging and therapy","volume":"14","author":"Parakh","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0015","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1158\/1078-0432.CCR-11-0483","article-title":"Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends","volume":"17","author":"Steiner","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0020","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3390\/ph17040508","article-title":"Approaches to reducing normal tissue radiation from radiolabeled antibodies","volume":"17","author":"Suzuki","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051378","article-title":"Optimizing the safety and efficacy of bio-radiopharmaceuticals for cancer therapy","volume":"15","author":"Funeh","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0030","first-page":"1149","article-title":"Pharmacokinetics of the monoclonal antibody B72. 3 and its fragments labeled with either 125I or 111In","volume":"47","author":"Brown","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0035","first-page":"3776","article-title":"Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms","volume":"53","author":"Yokota","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0040","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1517\/17425247.2014.941803","article-title":"Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer","volume":"11","author":"D\u2019Huyvetter","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0045","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-05-3521","article-title":"Tumor imaging using a picomolar affinity HER2 binding affibody molecule","volume":"66","author":"Orlova","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0050","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/cmdc.201800624","article-title":"Antibody fragment and affibody immunoPET imaging agents: radiolabelling strategies and applications","volume":"13","author":"Fu","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0055","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2967\/jnumed.110.075101","article-title":"Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention","volume":"51","author":"Vegt","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0060","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.addr.2008.04.005","article-title":"Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins","volume":"60","author":"Akizawa","year":"2008","journal-title":"Adv Drug Del Rev"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0065","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/ph17020256","article-title":"Towards the magic radioactive bullet: improving targeted radionuclide therapy by reducing the renal retention of radioligands","volume":"17","author":"de Roode","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nucmedbio.2020.03.001","article-title":"Renal brush border strategy: a developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides","volume":"92","author":"Arano","year":"2021","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1021\/bc0602329","article-title":"Design, synthesis, and evaluation of [188Re]organorhenium-labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels","volume":"18","author":"Uehara","year":"2007","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0080","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1158\/1078-0432.CCR-18-0123","article-title":"Gallium-67\/68-labeled antibody fragments for immuno-SPECT\/PET show low renal radioactivity without loss of tumor uptake","volume":"24","author":"Uehara","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0085","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1021\/acs.jmedchem.8b00198","article-title":"Preferential cleavage of a tripeptide linkage by enzymes on renal brush border membrane to reduce renal radioactivity levels of radiolabeled antibody fragments","volume":"61","author":"Suzuki","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0090","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1021\/acs.bioconjchem.0c00541","article-title":"Renal handling of 99mTc-labeled antibody fab fragments with a linkage cleavable by enzymes on brush border membrane","volume":"31","author":"Uehara","year":"2020","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0095","doi-asserted-by":"crossref","first-page":"21556","DOI":"10.1021\/acsomega.1c02516","article-title":"Copper-64-labeled antibody fragments for immuno-PET\/radioimmunotherapy with low renal radioactivity levels and amplified tumor-kidney ratios","volume":"6","author":"Suzuki","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C3CS60304K","article-title":"Matching chelators to radiometals for radiopharmaceuticals","volume":"43","author":"Price","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0105","doi-asserted-by":"crossref","first-page":"8600","DOI":"10.1021\/acs.jmedchem.3c00258","article-title":"Reduction of the renal radioactivity of 111In-DOTA-labeled antibody fragments with a linkage cleaved by the renal brush border membrane enzymes","volume":"66","author":"Suzuki","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0110","article-title":"Reduction of the hepatic radioactivity levels of [111In]In-DOTA\u2013labeled antibodies via cleavage of a linkage metabolized in lysosomes","volume":"132","author":"Suzuki","year":"2024","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0928-0987(97)10019-7","article-title":"Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs\u2019 lipophilicity and molecular weight","volume":"6","author":"Camenisch","year":"1998","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nucmedbio.2022.08.003","article-title":"Synthesis and evaluation of a para-carboxylated benzyl-DOTA for labeling peptides and polypeptides","volume":"114","author":"Suzuki","year":"2022","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0125","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/ct800246v","article-title":"Exploring the limit of accuracy of the global hybrid meta density functional for main-group thermochemistry, kinetics, and noncovalent interactions","volume":"4","author":"Zhao","year":"2008","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0130","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1021\/ic0349914","article-title":"Synthesis, characterization, and X-ray crystal structure of In (DOTA-AA)(AA= p-aminoanilide): a model for 111In-labeled DOTA-biomolecule conjugates","volume":"42","author":"Liu","year":"2003","journal-title":"Inorg Chem"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0135","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.1021\/ic7010452","article-title":"Synthesis and structural characterization of complexes of a DO3A-conjugated triphenylphosphonium cation with diagnostically important metal ions","volume":"46","author":"Yang","year":"2007","journal-title":"Inorg Chem"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0140","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1021\/bc050211z","article-title":"In vitro system to estimate renal brush border enzyme-mediated cleavage of peptide linkages for designing radiolabeled antibody fragments of low renal radioactivity levels","volume":"16","author":"Fujioka","year":"2005","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0145","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1021\/bc5004058","article-title":"67\/68Ga-labeling agent that liberates 67\/68Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels","volume":"25","author":"Uehara","year":"2014","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0003-9861(67)90426-2","article-title":"Determination of sulfhydryl groups with 2, 2\u2032-or 4, 4\u2032-dithiodipyridine","volume":"119","author":"Grassetti","year":"1967","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nprot.2006.49","article-title":"Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes","volume":"1","author":"Cooper","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0160","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0969-8051(99)00054-2","article-title":"Spectrophotometric method for determination of bifunctional macrocyclic ligands in macrocyclic ligand\u2013protein conjugates","volume":"26","author":"Dadachova","year":"1999","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0165","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.bmc.2011.11.046","article-title":"Facile synthesis and evaluation of C-functionalized benzyl-1-oxa-4, 7, 10-triazacyclododecane-N,N\u2019,N\u2033-triacetic acid as chelating agent for 111In-labeled polypeptides","volume":"20","author":"Suzuki","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0170","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/bc700453h","article-title":"An 86Y-labeled mirror-image oligonucleotide: influence of Y-DOTA isomers on the biodistribution in rats","volume":"19","author":"Schlesinger","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0175","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.HYP.0000244543.91937.79","article-title":"Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study","volume":"48","author":"Rice","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nucmedbio.2010.10.005","article-title":"Development of positron emission tomography probe of 64Cu-labeled anti-C-kit 12A8 Fab to measure protooncogene C-kit expression","volume":"38","author":"Yoshida","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109638_bb0185","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.2c01472","article-title":"Enzymological characterization of 64Cu-labeled neprilysin substrates and their application for modulating the renal clearance of targeted radiopharmaceuticals","author":"Brandt","year":"2023","journal-title":"J Med Chem"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:25:21Z","timestamp":1786620321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805126000375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S0969805126000375"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109638","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Importance of an alkyl group inserted into the DOTA backbone for reducing renal radioactivity levels of 111In-labeled antibody fragments","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109638"}}